Lv3
314 积分 2023-06-13 加入
Targeting systemic IL-2 to BCMA CAR-T cells
2个月前
已完结
A CAR enhancer increases the activity and persistence of CAR T cells
2个月前
已完结
Armed with IL-2 based fusion protein improves CAR-T cell fitness and efficacy against solid tumors
2个月前
已完结
γδ T cells for cancer immunotherapy: A 2024 comprehensive systematic review of clinical trials
2个月前
已完结
Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy
2个月前
已完结
Co-Expression of IL-15 and CCL21 Strengthens CAR-NK Cells to Eliminate Tumors in Concert with T Cells and Equips Them with Higher PI3K/AKT/mTOR Signal Signature
3个月前
已关闭
Co-Expression of IL-15 and CCL21 Strengthens CAR-NK Cells to Eliminate Tumors in Concert with T Cells and Equips Them with Higher PI3K/AKT/mTOR Signal Signature
3个月前
已关闭
Co-Expression of IL-15 and CCL21 Strengthens CAR-NK Cells to Eliminate Tumors in Concert with T Cells and Equips Them with Higher PI3K/AKT/mTOR Signal Signature
3个月前
已关闭
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
3个月前
已完结
γδ T cells as critical anti-tumor immune effectors
6个月前
已完结
皖公网安备34019202002308
